DWAS.US Invesco DWA SmallCap Momentum ETF
- Total assets
- 391M
- Expense ratio
- 0.57%
- Dividend yield
- 0.03%
- 1-year return
- +13.32%
- Holdings
- 201
- Since
- 2012
Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.
What does DWAS.US invest in?
- Mostly US stocks (98.2%)
- Largest sector: Healthcare (46.3%)
- Largest region: North America (97.4%)
- Top 3 holdings: 5.3% of the fund
Asset allocation
- US stocks 98.2%
- Non-US stocks 1.5%
- Cash 0.1%
Top holdings
- Replimune Group Inc 1.93%
- Amneal Pharmaceuticals, Inc. Class A Common Stock 1.71%
- Alto Neuroscience, Inc. 1.68%
- Brightsphere Investment Group Inc 1.57%
- Oruka Therapeutics, Inc. 1.56%
Invesco DWA SmallCap Momentum ETF performance
Sharpe ratio 0.56- This year
- +9.11%
- 1 year
- +13.32%
- 3 years
- +14.66%
- 5 years
- +2.38%
Volatility 23.5% over 1 year and 21.9% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DWAS.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Invesco DWA SmallCap Momentum ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of approximately 200 securities from an eligible universe of approximately 2,000 securities ranked 1,001 to 3,000 by market capitalization within the NASDAQ US Benchmark Index".
Full fund profileInvesco DWA SmallCap Momentum ETF top holdings
14.8% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Replimune Group Inc REPL.US | Healthcare | United States | 1.93% |
| Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX.US | Healthcare | United States | 1.71% |
| Alto Neuroscience, Inc. ANRO.US | Healthcare | United States | 1.68% |
| Brightsphere Investment Group Inc BSIG.US | Financial Services | United States | 1.57% |
| Oruka Therapeutics, Inc. ORKA.US | Healthcare | United States | 1.56% |
| Victory Capital Holdings Inc VCTR.US | Financial Services | United States | 1.48% |
| Adaptive Biotechnologies Corp ADPT.US | Healthcare | United States | 1.40% |
| Frequency Electronics Inc FEIM.US | Technology | United States | 1.28% |
| Xometry Inc XMTR.US | Industrials | United States | 1.22% |
| Northeast Bancorp NBN.US | Financial Services | United States | 1.01% |
The 10 largest of 201 holdings.
DWAS.US sector exposure
- Healthcare46.3%
- Financial Services17.5%
- Technology12.0%
- Industrials10.2%
- Consumer Cyclicals5.6%
- Energy4.1%
- Communication Services2.6%
- Basic Materials1.7%
- Consumer Defensive0.9%
- Real Estate0.8%
Share of the stocks in the fund.
DWAS.US regional exposure
- North America97.4%
- Latin America0.9%
- Europe Developed0.3%
- United Kingdom0.3%
Share of the stocks in the fund.
Company size
Average market cap 2.43B- Medium cap1.2%
- Small cap34.0%
- Micro cap64.0%
Invesco DWA SmallCap Momentum ETF fund profile
- Fund name
- Invesco DWA SmallCap Momentum ETF
- Ticker
- DWAS.US
- Exchange
- USA Stocks
- Issuer
- Invesco
- Index tracked
- -
- Category
- US Small & Mid Cap Equity
- Domicile
- United States
- Inception date
- Jul 19, 2012
- Trading currency
- USD
- Expense ratio
- 0.57%
- Annual turnover
- 1.9%
About Invesco DWA SmallCap Momentum ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of approximately 200 securities from an eligible universe of approximately 2,000 securities ranked 1,001 to 3,000 by market capitalization within the NASDAQ US Benchmark Index".